Europe’s medicines regulator recommended the suspension of Medtronic Plc’s Inductos, an implant used to help bone development, pending the resolution of issues at a U.S. site where a component is made. The European Medicines Agency (EMA) began a review of

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone